Amarin Corp Plc (AMRN)

[Dancing in the dark]

Zakrzewski joins LipoScience as a director.

"LipoScience, Inc. (Nasdaq: LPDX) is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. The NMR LipoProfile® test, the Company's first proprietary test, is the only FDA-cleared blood test that directly quantifies LDL particles and provides physicians and their patients with actionable information to personalize management of heart disease. To date, more than 11 million NMR LipoProfile tests have been ordered. LipoScience is striving toward the NMR LipoProfile test becoming the preferred choice by physicians for the management of cardiovascular disease."


http://files.shareholder.com/downloads/AMDA-ZIFX5/3246096513x0xS1127602-14-20811/1168197/filing.pdf